Pharmabiz

Bristol Myers Squibb Builds on Eliquis direct-to-patient programme, announces new BMS Patient Connect platform offering Sotyktu

Bristol Myers Squibb announced an expansion of its direct-to-patient offerings, providing eligible US patients with steeply discounted prices for Eliquis (apixaban) and Sotyktu (deucravacitinib).
EE World Online

PXI/PXIe battery simulators automate BMS testing

Pickering Interfaces has added two PXI and two PXIe battery simulators to its line of PXI test modules. The 41-754 (PXI) and ...
Seeking Alpha

Bristol Myers Squibb Builds on Eliquis® (apixaban) Direct-to-Patient Program, Announces New BMS Patient Connect Platform Offering Sotyktu® (deucravacitinib)

Eliquis Offered to Cash-Paying Patients at More Than 40% Discount to Current List Price, Sotyktu at More Than 80% Discount to Current List Price PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb ...
The Bakersfield Californian

Bristol Myers Squibb Builds on Eliquis® (apixaban) Direct-to-Patient Program, Announces New BMS Patient Connect Platform Offering Sotyktu® (deucravacitinib)

Bristol Myers Squibb (NYSE: BMY) today announced an expansion of its direct-to-patient offerings, providing eligible U.S. patients with steeply discounted prices for Eliquis ® (apixaban) and Sotyktu ® ...